'The mRNA-LNP platform's lipid nanoparticle component used in | Robert W Malone, MD
"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory" https://pubmed.ncbi.nlm.nih.gov/34841223/
... "characterized by massive neutrophil infiltration, activation of diverse inflammatory pathways, & prod. of various inflammatory cytokines & chemokines. The same dose of LNP delivered intranasally led to similar inflam. responses in the lung & resulted in a high mortality rate" ... We first disclosed this observation in the mid 1990s. Katlin Kariko was at that conference in Annapolis - by my invitation. ... "Here we present evidence that Acuitas' LNPs used in preclinical nucleoside-modified mRNA vaccine studies are highly inflammatory in mice. Intradermal and intramuscular injection of these LNPs led to rapid and robust inflammatory responses,"
